Discontinue Plavix for 5 Days Before Melanoma Surgery
For a patient with a lacunar infarction 9 months ago, clopidogrel (Plavix) should be stopped 5 days before melanoma surgery. This recommendation balances the bleeding risk of melanoma excision against the thrombotic risk in a patient with prior stroke.
Rationale for 5-Day Discontinuation
The FDA label for Plavix explicitly states: "When possible, interrupt therapy with Plavix for five days prior to such surgery" for procedures with major bleeding risk 1. This is based on the pharmacology of clopidogrel, which irreversibly inhibits platelets for their 7-10 day lifespan 1. After 5 days of discontinuation, sufficient new platelets have been generated to restore adequate hemostasis (requiring at least 20% of circulating platelets to have normal function).
The 2022 ACCP perioperative guidelines support this approach, recommending P2Y12 inhibitor interruption prior to surgery, with specific mention of 5-day discontinuation for clopidogrel in cardiac surgery contexts where bleeding risk is substantial 2.
Why 5 Days is Appropriate for Melanoma Surgery
Melanoma excision, particularly wide local excision or sentinel lymph node biopsy, carries moderate bleeding risk. While not as high-risk as intracranial or cardiac surgery, the surgical field requires meticulous hemostasis and bleeding can compromise oncologic outcomes. The 5-day window provides:
- Adequate platelet recovery for normal hemostasis
- Minimized surgical bleeding complications
- Acceptable thrombotic risk given the 9-month interval since stroke
Recent data shows that even with 7+ days of clopidogrel discontinuation, patients still experience higher reoperation rates for bleeding compared to non-clopidogrel patients 3, suggesting that 5 days represents a reasonable minimum rather than an excessive precaution.
Thrombotic Risk Considerations
The 9-month timeframe since lacunar infarction is crucial. The highest risk period for recurrent stroke is within the first 90 days after the initial event. At 9 months post-stroke, your patient is in a lower-risk phase for recurrence, making a 5-day interruption more acceptable than it would be in the acute period.
The FDA label warns: "Discontinuation of Plavix increases the risk of cardiovascular events" 1. However, this risk must be weighed against surgical bleeding. For a patient 9 months post-lacunar stroke undergoing necessary cancer surgery, the 5-day interruption represents an acceptable risk-benefit balance.
Critical Management Points
Resume clopidogrel as soon as hemostasis is achieved postoperatively 1. The FDA label emphasizes restarting "as soon as possible" after temporary discontinuation. For most melanoma surgeries, this typically means:
- Within 12-24 hours if hemostasis is secure
- No significant wound bleeding or hematoma formation
- Surgical drains (if placed) have minimal output
Do NOT use bridging therapy with low-molecular-weight heparin (LMWH). Recent evidence shows LMWH bridging does not protect against arterial thrombosis and may actually increase bleeding risk 4, 5. Bridging is ineffective for preventing stroke or stent thrombosis in patients on antiplatelet therapy.
Common Pitfalls to Avoid
- Don't delay surgery beyond 5 days unnecessarily - Longer discontinuation doesn't significantly reduce bleeding risk further but does increase thrombotic risk
- Don't substitute aspirin monotherapy during the interruption - Either continue aspirin alone (if patient was on dual therapy) or accept the brief interruption
- Don't rely on platelet transfusions prophylactically - Reserve platelets for active bleeding; prophylactic transfusion is ineffective within 4 hours of loading dose or 2 hours of maintenance dose 1
- Ensure meticulous surgical hemostasis - Even with 5-day discontinuation, these patients have residual antiplatelet effects 6
Coordination with Surgical and Cardiology Teams
Communicate the plan clearly:
- Inform the surgeon that the patient will be off clopidogrel for 5 days preoperatively
- Have platelets available in the operating room if needed
- Document the last dose of clopidogrel and planned resumption date
- Consider cardiology consultation if there are concerns about the patient's specific thrombotic risk profile, though at 9 months post-lacunar stroke without other high-risk features (like recent stent placement), this is typically unnecessary